Information Session

OTHER3 trials

Sponsors

University of Göttingen, University of Arizona, National Institute of Mental Health, Czech Republic

Conditions

AcrophobiaAnxietyAnxiety DisordersCoronary Artery DiseaseDepressionFear of HeightsMental HealthPerformance

Unknown Phase

Effects of a Psychotherapy Intervention in Depressed Patients With Coronary Artery Disease

CompletedNCT00705965

University of GöttingenCoronary Artery Disease, Depression

Start: 2008-11-30End: 2013-04-30Updated: 2016-08-30

Recovery Enhancement and Sleep Training

CompletedNCT02982239

University of ArizonaAnxiety, Mental Health, Performance +2

Start: 2016-06-30End: 2017-01-05Updated: 2019-07-19

Virtual Reality Exposure Therapy for Acrophobia

CompletedNCT04975854

National Institute of Mental Health, Czech RepublicAcrophobia, Anxiety Disorders, Fear of Heights +1

Start: 2021-07-13End: 2022-06-17Updated: 2024-05-16

Related Papers

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2019-05-218 citations

Somatic and sociodemographic predictors of depression outcome among depressed patients with coronary artery disease - a secondary analysis of the SPIRR-CAD study.

2019-02-049 citations

The relationship between attachment orientations and the course of depression in coronary artery disease patients: A secondary analysis of the SPIRR-CAD trial.

2018-02-244 citations

Socioeconomic factors in coronary artery disease - Results from the SPIRR-CAD study.

2017-12-056 citations

Prevalence of mental disorders among depressed coronary patients with and without Type D personality. Results of the multi-center SPIRR-CAD trial

General Hospital Psychiatry2017-10-1237 citations

A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): Results of an Observer-Blinded, Multicenter, Randomized Trial in Depressed Patients With Coronary Artery Disease

Psychosomatic Medicine2016-05-1794 citations

A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD.

2011-04-1531 citations